The role of macrophage migration inhibitory factor in mouse islet transplantation

Transplantation

Volumn 86, Issue 10, 2008, Pages 1361-1369

  Toso, Christian ^a,b   Serre Beinier, Véronique ^b   Emamaullee, Juliet ^a   Merani, Shaheed ^a   Armanet, Mathieu ^b   Wojtusciszyn, Anne ^b   Bosco, Domenico ^b   Calandra, Thierry ^c   Roger, Thierry ^c   Morel, Philippe ^b   Shapiro, A M James ^a   Berney, Thierry ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Cytokine; Islet; Macrophage; Transplantation.

Indexed keywords

GLUCOSE; INSULIN; MACROPHAGE MIGRATION INHIBITION FACTOR; ISOMERASE; MIF PROTEIN, MOUSE; UNCLASSIFIED DRUG;

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; GLUCOSE METABOLISM; GRAFT REJECTION; INSULIN METABOLISM; MACROPHAGE; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN FUNCTION; ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; BLOOD; C57BL MOUSE; CROSS BREEDING; EXPERIMENTAL DIABETES MELLITUS; GENETICS; GLUCOSE BLOOD LEVEL; GRAFT SURVIVAL; IMMUNOLOGY; INFLAMMATION; MACROPHAGE ACTIVATION; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; TREATMENT OUTCOME;

ANIMALS; APOPTOSIS; BLOOD GLUCOSE; CROSSES, GENETIC; DIABETES MELLITUS, EXPERIMENTAL; GRAFT REJECTION; GRAFT SURVIVAL; INFLAMMATION; INTRAMOLECULAR OXIDOREDUCTASES; ISLETS OF LANGERHANS TRANSPLANTATION; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; TREATMENT OUTCOME;

EID: 58149339700     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31818bdbef     Document Type: Article

References (39)

1. Calandra T, Roger T. Macrophage migration inhibitory factor: A regulator of innate immunity. Nat Rev Immunol 2003; 3: 791.
2. Bacher M, Meinhardt A, Lan HY, et al. Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol 1997; 150: 235.
3. Emonts M, Sweep FC, Grebenchtchikov N, et al. Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis. Clin Infect Dis 2007; 44: 1321.
4. Bernhagen J, Calandra T, Mitchell RA, et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993; 365: 756.
5. Bozza M, Satoskar AR, Lin G, et al. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med 1999; 189: 341.
6. Calandra T, Echtenacher B, Le Roy D, et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 2000; 6: 164.
7. Calandra T, Bernhagen J, Mitchell RA, et al. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 1994; 179: 1895.
8. Roger T, David J, Glauser MP, et al. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 2001; 414: 920.
9. Roger T, Froidevaux C, Martin C, et al. Macrophage migration inhibitory factor (MIF) regulates host responses toendotoxin through modulation of Toll-like receptor 4 (TLR4). J Endotoxin Res 2003; 9: 119.
10. Toh ML, Aeberli D, Lacey D, et al. Regulation ofIL-1 and TNF receptor expression and function by endogenous macrophage migration inhibitory factor. J Immunol 2006; 177: 4818.
11. Bernhagen J, Mitchell RA, Calandra T, et al. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 1994; 33: 14144.
12. Bernhagen J, Krohn R, Lue H, et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 2007; 13: 587.
13. Bacher M, Metz C, Calandra T, et al. An essential regulatory role for macrophage migration inhibitory factor in the T-cell activation. Proc Natl Acad Sci USA 1996; 93: 7849.
14. Gore Y, Starlets D, Maharshak N, et al. Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex. J Biol Chem 2008; 283: 2784.
15. Lan HY, Yang N, Brown FG, et al. Macrophage migration inhibitory factor expression in human renal allograft rejection. Transplantation 1998; 66: 1465.
16. Brown F, Nikolic-Paterson D, Metz C, et al. Up-regulation of macrophage migration inhibitory factor in acute renal allograft rejection in the rat. Clin Exp Immunol 1999; 118: 329.
17. Demir Y, Chen Y, Metz C, et al. Cardiac allograft rejection in the absence of macrophage migration inhibitory factor. Transplantation 2003; 76: 244.
18. Hou G, Valujskikh A, Bayer J, et al. In vivo blockade of macrophage migration inhibitory factor prevents skin graft destruction after indirect allorecognition. Transplantation 2001; 72: 1890.
19. Fukuyama S, Yoshino I, Yamaguchi M, et al. Blockage of the macro phage migration inhibitory factor expression by the short interference RNA inhibited the rejection of an allogeneic tracheal graft. Transpl Int 2005; 18: 1203.
20. Jose M, David J, Akins C, et al. Blockade of macrophage migration inhibitory factor does not prevent acute renal allograft rejection. Am J Transplant 2003; 3: 1099.
21. Biarnes M, Montolio M, Nacher V, et al. Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes 2002; 51: 66.
22. Johansson H, Lukinius A, Moberg L, et al. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 2005; 54: 1755.
23. Piemonti L, Leone BE, Nano R, et al. Human pancreatic islets produce and secrete MCP-1/CCL2: Relevance in human islet transplantation. Diabetes 2002; 51: 55.
24. Barshes NR, Wyllie S, Goss JA. Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: Implications for intrahepatic grafts. J Leukoc Biol 2005; 77: 587.
25. Waeber G, Calandra T, Roduit R, et al. Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor. Proc Natl Acad Sci USA 1997; 94: 4782.
26. Johansson U, Olsson A, Gabrielsson S, et al. Inflammatory mediators expressed in human islets of Langerhans: Implications for islet transplantation. Biochem Biophys Res Commun 2003; 308: 474.
27. Worcester Human Islet Transplantation Group. Autoimmunity after islet-cell allotransplantation. N Engl J Med 2006; 355: 1397.
28. Cvetkovic I, Al-Abed Y, Miljkovic D, et al. Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes. Endocrinology 2005; 146: 2942.
29. Stosic-Grujicic S, Stojanovic I, Maksimovic-Ivanic D, et al. Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus. J Cell Physiol 2008; 215: 665.
30. Toso C, Emamaullee JA, Merani S, et al. The role of macrophage migration inhibitory factor on glucose metabolism and diabetes. Diabetologia 2008; 51:1937.
31. Merani S, Truong W, Emamaullee JA, et al. Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves glucose homeostasis in marginal mass islet transplantation in mice. Endocrinology 2008; 149: 4322.
32. Kaufman DB, Gores PF, Field MJ, etal. Effect of15-deoxyspergualin on immediate function and long-term survival of transplanted islets in murine recipients of a marginal islet mass. Diabetes 1994; 43: 778.
33. Emamaullee JA, DavisJ, Pawlick R,etal. The caspase selective inhibitor EP1013 augments human islet graft function and longevity in marginal mass islet transplantation in mice. Diabetes 2008; 57: 1556.
34. Emamaullee JA, Stanton L, Schur C, et al. Caspase inhibitor therapy enhances marginal mass islet graft survival and preserves long-term function in islet transplantation. Diabetes 2007; 56: 1289.
35. Toso C, Vallee JP, Morel P, et al. Clinical magnetic resonance imaging of pancreatic islet grafts after iron nanoparticle labeling. Am J Transplant 2008; 8: 701.
36. Pileggi A, Molano RD, Berney T, et al. Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 2001; 50: 1983.
37. Zhang YC, Molano RD, Pileggi A, et al. Adeno-associated virus transduction of islets with interleukin-4 results in impaired metabolic function in syngeneic marginal islet mass transplantation. Transplantation 2002; 74: 1184.
38. Atsumi T, Cho YR, Leng L, et al. The proinflammatory cytokine macrophage migration inhibitory factor regulates glucose metabolism during systemic inflammation. J Immunol 2007; 179: 5399.
39. Mizue Y, Ghani S, Leng L, et al. Role for macrophage migration inhibitory factor in asthma. Proc Natl Acad Sci USA 2005; 102: 14410.